Cargando…

Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia

BACKGROUND: CD26 is expressed in all chronic myeloid leukemia (CML) patients. This study investigated the role of CD26(+) LSCs in diagnosis and follow up of CML patients. METHOD: Flow cytometry was performed to evaluate CD26(+) LSC in peripheral blood (PB) in CML patients. BCR-ABL1 transcript level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebian, Huda F, Abdelnabi, AL-Shabrawy M., Abdelazem, Abdallah S., Khamis, Tarek, Fawzy, Hebatallah M., Hussein, Samia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118510/ https://www.ncbi.nlm.nih.gov/pubmed/35602932 http://dx.doi.org/10.1016/j.lrr.2022.100321

Ejemplares similares

Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic Leukemia
por: Hussein, Samia, et al.
Publicado: (2022)

The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia
por: Galimberti, Sara, et al.
Publicado: (2018)

Residual Peripheral Blood CD26(+) Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission
por: Bocchia, Monica, et al.
Publicado: (2018)

Flow Cytometry Assessment of CD26(+) Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia
por: Raspadori, Donatella, et al.
Publicado: (2019)

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects
por: Culen, Martin, et al.
Publicado: (2016)

Leukemic stem cells and therapy resistance in acute myeloid leukemia
por: Stelmach, Patrick, et al.
Publicado: (2023)

CD26/DPP-4 in Chronic Myeloid Leukemia
por: Sicuranza, Anna, et al.
Publicado: (2022)

A Case of Leukemic Pleural Infiltration in Atypical Chronic Myeloid Leukemia
por: Kim, Hyun Woo, et al.
Publicado: (2006)

Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
por: Soverini, Simona, et al.
Publicado: (2021)

Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia
por: Rogers, Sally L, et al.
Publicado: (2010)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019)

Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients
por: Ricciardi, Maria Rosaria, et al.
Publicado: (2018)

P452: CD4+ T CELLS REDUCE THE POPULATION OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA
por: Schnüriger, Noah, et al.
Publicado: (2023)

A Novel Application of Furazolidone: Anti-Leukemic Activity in Acute Myeloid Leukemia
por: Jiang, Xueqing, et al.
Publicado: (2013)

Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia
por: Mouchel, Pierre-Luc, et al.
Publicado: (2020)

Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia
por: Han, Heejoo, et al.
Publicado: (2021)

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26(+) leukemia stem cells
por: Pacelli, Paola, et al.
Publicado: (2023)

Extramedullary Acute Myeloid Leukemia: Leukemic Pleural Effusion, Case Report and Review of the Literature
por: Pemmaraju, Naveen, et al.
Publicado: (2014)

Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
por: Laverdière, Isabelle, et al.
Publicado: (2018)

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
por: Depreter, Barbara, et al.
Publicado: (2020)

Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias
por: Zhai, Xingjian, et al.
Publicado: (2022)

Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication
por: Rickmann, Mareike, et al.
Publicado: (2011)

Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias
por: Swatler, Julian, et al.
Publicado: (2022)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

Surface morphology of leukemic cells from chronic myeloid leukemia under atomic force microscopy
por: Gaman, Amelia, et al.
Publicado: (2013)

Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
por: Terwijn, Monique, et al.
Publicado: (2014)

Bullous drug eruption with leukemic cell infiltrate in the setting of new-onset acute myeloid leukemia
por: Khanna, Trisha, et al.
Publicado: (2017)

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
por: Rothenberg-Thurley, Maja, et al.
Publicado: (2018)

In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia
por: Strese, Sara, et al.
Publicado: (2016)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)

Feasibility of tumor-derived exosome enrichment in the onco-hematology leukemic model of chronic myeloid leukemia
por: Bernardi, Simona, et al.
Publicado: (2019)

Anti-Leukemic Activity of Brassica-Derived Bioactive Compounds in HL-60 Myeloid Leukemia Cells
por: Núñez-Sánchez, María Ángeles, et al.
Publicado: (2022)

Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
por: Han, Lina, et al.
Publicado: (2010)

Curcumin Down-Regulates DNA Methyltransferase 1 and Plays an Anti-Leukemic Role in Acute Myeloid Leukemia
por: Yu, Jianhua, et al.
Publicado: (2013)

IGK with conserved IGKV/IGKJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration
por: Wang, Chong, et al.
Publicado: (2015)

Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
por: Lee, Hyo Jeong, et al.
Publicado: (2017)

Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
por: Herrmann, Oliver, et al.
Publicado: (2019)

Characterization of FLT3-ITD(mut) acute myeloid leukemia: molecular profiling of leukemic precursor cells
por: Travaglini, Serena, et al.
Publicado: (2020)

Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia
por: Parting, Oliver, et al.
Publicado: (2020)

Two autopsy cases of pulmonary leukemic infiltration mimicking severe pneumonia in patients with acute myeloid leukemia
por: Iizuka, Hiroko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nqp85aatou2o756bjv2qmiihjk